ESSA Pharma Inc.

25.00-0.2000-0.79%Vol 223.87K1Y Perf 287.60%
Jul 23rd, 2021 16:00 DELAYED
BID24.94 ASK25.00
Open25.36 Previous Close25.20
Pre-Market- After-Market-
 - -  - -%
Target Price
42.00 
Analyst Rating
Strong Buy 1.00
Potential %
68.00 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/100/100 
Income Ranking
 —    -
Market Cap1.01B 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
64.05 
Earnings Date
5th Aug 2021

Today's Price Range

24.4426.34

52W Range

5.4036.00

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
0.12%
1 Month
-9.09%
3 Months
-8.12%
6 Months
37.36%
1 Year
287.60%
3 Years
681.25%
5 Years
792.86%
10 Years
-

TickerPriceChg.Chg.%
EPIX25.00-0.2000-0.79
AAPL148.561.76001.20
GOOG2 756.3289.75003.37
MSFT289.673.53001.23
XOM57.04-0.0700-0.12
WFC44.59-0.4400-0.98
JNJ171.791.81001.06
FB369.7918.60005.30
GE12.710.01000.08
JPM150.64-0.2900-0.19
Earnings HistoryEstimateReportedSurprise %
Q02 2021-0.21-0.36-71.43
Q01 2021-0.17-0.20-17.65
Q04 2020-0.20-0.1715.00
Q03 2020-0.29-0.2417.24
Q02 2020-0.20-0.45-125.00
Q01 2020-0.17-0.22-29.41
Q04 2019-0.15-0.0660.00
Q03 2019-0.54-0.523.70
Earnings Per EndEstimateRevision %Trend
6/2021 QR-0.26-18.18Negative
9/2021 QR-0.31-29.17Negative
9/2021 FY-1.12-30.23Negative
9/2022 FY-1.25-27.55Negative
Next Report Date5th Aug 2021
Estimated EPS Next Report-0.26
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume223.87K
Shares Outstanding40.46M
Trades Count3.27K
Dollar Volume4.34M
Avg. Volume298.49K
Avg. Weekly Volume412.10K
Avg. Monthly Volume249.09K
Avg. Quarterly Volume240.52K

ESSA Pharma Inc. (NASDAQ: EPIX) stock closed at 25 per share at the end of the most recent trading day (a -0.79% change compared to the prior day closing price) with a volume of 223.87K shares and market capitalization of 1.01B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 25 people. ESSA Pharma Inc. CEO is David R. Parkinson.

The one-year performance of ESSA Pharma Inc. stock is 287.6%, while year-to-date (YTD) performance is 109.56%. EPIX stock has a five-year performance of 792.86%. Its 52-week range is between 5.4 and 36, which gives EPIX stock a 52-week price range ratio of 64.05%

ESSA Pharma Inc. currently has a PE ratio of -, a price-to-book (PB) ratio of 2.12, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -22.77%, a ROC of -23.53% and a ROE of -23.34%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from ESSA Pharma Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.26 for the next earnings report. ESSA Pharma Inc.’s next earnings report date is 05th Aug 2021.

The consensus rating of Wall Street analysts for ESSA Pharma Inc. is Strong Buy (1), with a target price of $42, which is +68.00% compared to the current price. The earnings rating for ESSA Pharma Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

ESSA Pharma Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

ESSA Pharma Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 42.05, ATR14 : 1.77, CCI20 : -99.90, Chaikin Money Flow : -0.10, MACD : -0.85, Money Flow Index : 41.82, ROC : -4.29, RSI : 39.20, STOCH (14,3) : 13.76, STOCH RSI : 0.30, UO : 47.38, Williams %R : -86.24), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of ESSA Pharma Inc. in the last 12-months were: Franklin M. Berger (Buy at a value of $1 539 000)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.

CEO: David R. Parkinson

Telephone: +1 778 331-0962

Address: 999 West Broadway Street, Vancouver V5Z 1K5, BC, CA

Number of employees: 25

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

58%42%

News

Stocktwits